ABL1 and amyotrophic lateral sclerosis: Moreover, the pharmacological inhibition of c-Abl in an ALS mouse model improves mitochondrial health and delays the onset of symptoms, opening avenues for further research and potential treatments in neurodegenerative conditions linked to cellular stress and mitochondrial dysfunction.